Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-25

Clinical Trial Update: Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing the investigation of Antroquinonol in combination with standard of care for first-line metastatic pancreatic cancer (Phase 1/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antroquinonol (antroquinonol)

Snippet

Sponsor: Golden Biotechnology Corporation | Conditions: Pancreatic Neoplasm | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING